• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服避孕药与营养需求变化。

Oral contraceptives and changes in nutritional requirements.

机构信息

Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.

出版信息

Eur Rev Med Pharmacol Sci. 2013 Jul;17(13):1804-13.

PMID:23852908
Abstract

Oral contraceptives (OCs) are a major class of prescription drug, used by a large proportion of women starting from early adolescence. Much research has been conducted to investigate the physiological changes that occur in women who take OCs. These include changes in general health as well as in nutritional needs. In terms of nutrition, several studies investigated whether women on OCs need different amounts of some vitamins and minerals. In particular, a report from the World Health Organization (WHO) points out that the influence of OCs on nutrient requirements is a topic of high clinical relevance and should, therefore, receive great attention. It has been shown that the key nutrient depletions concern folic acid, vitamins B2, B6, B12, vitamin C and E and the minerals magnesium, selenium and zinc. Most research has focused on the levels of these vitamins and minerals in the blood of women who take OCs compared to women who do not. Since women who take OCs not always have adequate diet, may have unhealthy life style or may suffer from pathologies of malabsorption, the possibility to prevent vitamin and mineral deficiencies by taking appropriate dietary supplements should be considered a first-line approach by clinicians.

摘要

口服避孕药(OCs)是一类主要的处方药,很大一部分女性从青春期早期就开始服用。大量研究已经对服用 OCs 的女性发生的生理变化进行了研究。这些变化包括一般健康状况以及营养需求的变化。在营养方面,一些研究调查了服用 OCs 的女性是否需要不同数量的某些维生素和矿物质。特别是,世界卫生组织(WHO)的一份报告指出,OCs 对营养需求的影响是一个具有高度临床相关性的话题,因此应该引起高度关注。已经表明,关键的营养物质耗竭涉及叶酸、维生素 B2、B6、B12、维生素 C 和 E 以及矿物质镁、硒和锌。大多数研究都集中在服用 OCs 的女性与不服用 OCs 的女性的血液中这些维生素和矿物质的水平上。由于服用 OCs 的女性饮食并不总是充足,可能有不健康的生活方式或患有吸收不良的疾病,因此通过服用适当的膳食补充剂来预防维生素和矿物质缺乏症应该被临床医生视为一线方法。

相似文献

1
Oral contraceptives and changes in nutritional requirements.口服避孕药与营养需求变化。
Eur Rev Med Pharmacol Sci. 2013 Jul;17(13):1804-13.
2
Effect of oral contraceptive agents on vitamin and mineral requirements.口服避孕药对维生素和矿物质需求的影响。
J Am Diet Assoc. 1980 Jun;76(6):581-4.
3
Nutritional effects of oral contraceptive use: a review.口服避孕药的营养影响:综述
J Reprod Med. 1980 Oct;25(4):150-6.
4
Vitamin B6 status of young men, women, and women using oral contraceptives.年轻男性、女性以及使用口服避孕药的女性的维生素B6状况。
J Lab Clin Med. 1976 May;87(5):813-21.
5
Evaluation of prenatal vitamin-mineral supplements.产前维生素 - 矿物质补充剂的评估。
Clin Pharm. 1987 Oct;6(10):770-7.
6
Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes.使用维生素/矿物质补充剂的老年人在营养素摄入充足性和饮食态度方面与不使用者有所不同。
J Am Diet Assoc. 2007 Aug;107(8):1322-32. doi: 10.1016/j.jada.2007.05.010.
7
Nutrition during pregnancy, lactation, and oral contraception.孕期、哺乳期及口服避孕药期间的营养
Nurs Clin North Am. 1979 Jun;14(2):269-83.
8
[Evaluation of the dietary intake of vitamins and minerals in the daily food rations by the students of the Rzeszów University].[热舒夫大学学生日常食物定量中维生素和矿物质的膳食摄入量评估]
Rocz Panstw Zakl Hig. 2012;63(4):441-6.
9
Letter: Oral contraceptives and vitamin requirements.
Med J Aust. 1975 Mar 22;1(12):407.
10
Vitamin and mineral status: effects on physical performance.维生素和矿物质状况:对身体机能的影响。
Nutrition. 2004 Jul-Aug;20(7-8):632-44. doi: 10.1016/j.nut.2004.04.001.

引用本文的文献

1
Coagulation Profiles Among Combined Oral Contraceptive User and Non-User Women Attending at Family Guidance Association of Ethiopia, Jigjiga Medium Clinic: A Comparative Cross-Sectional Study.埃塞俄比亚吉吉加中等诊所计划生育协会中联合口服避孕药使用者与非使用者女性的凝血指标:一项比较性横断面研究
Open Access J Contracept. 2025 Sep 4;16:97-110. doi: 10.2147/OAJC.S544527. eCollection 2025.
2
Riboflavin for women's health and emerging microbiome strategies.核黄素与女性健康和新兴微生物组策略。
NPJ Biofilms Microbiomes. 2024 Oct 18;10(1):107. doi: 10.1038/s41522-024-00579-5.
3
Expert opinion on the use of contraception in people with multiple sclerosis.
专家关于多发性硬化症患者使用避孕措施的意见。
Mult Scler. 2024 Aug;30(9):1093-1106. doi: 10.1177/13524585241228103. Epub 2024 Mar 8.
4
Pharmacokinetics of vitamin dosage forms: A complete overview.维生素剂型的药代动力学:全面概述。
Food Sci Nutr. 2023 Nov 9;12(1):48-83. doi: 10.1002/fsn3.3787. eCollection 2024 Jan.
5
Lower levels of the neuroprotective tryptophan metabolite, kynurenic acid, in users of estrogen contraceptives.雌激素避孕药使用者中神经保护色氨酸代谢产物犬尿酸水平降低。
Sci Rep. 2023 Sep 29;13(1):16370. doi: 10.1038/s41598-023-43196-6.
6
Hematological parameters of reproductive-age women using hormonal contraceptives at University of Gondar Comprehensive Specialized Referral Hospital, Northwest Ethiopia: A comparative cross-sectional study.使用激素避孕药的育龄妇女的血液学参数:埃塞俄比亚西北部贡德尔大学综合专科医院的一项比较性横断面研究。
PLoS One. 2022 Nov 8;17(11):e0277254. doi: 10.1371/journal.pone.0277254. eCollection 2022.
7
Multimodal Care for Headaches, Lumbopelvic Pain, and Dysmenorrhea in a Woman With Endometriosis: A Case Report.子宫内膜异位症女性头痛、腰骶部疼痛和痛经的多模式护理:一例报告
J Chiropr Med. 2021 Sep;20(3):148-157. doi: 10.1016/j.jcm.2021.10.002. Epub 2022 Jan 31.
8
Medications and Micronutrients: Identifying Clinically Relevant Interactions and Addressing Nutritional Needs.药物与微量营养素:识别临床相关相互作用并满足营养需求。
J Pharm Technol. 2018 Oct;34(5):216-230. doi: 10.1177/8755122518780742. Epub 2018 Jun 20.
9
Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part Two.作为骨质疏松症次要病因的常用处方药和非处方药——第二部分。
Integr Med (Encinitas). 2021 Jun;20(3):8-14.
10
Risk factors and comorbidities associated with magnesium deficiency in pregnant women and women with hormone-related conditions: analysis of a large real-world dataset.与孕妇和激素相关疾病妇女镁缺乏相关的风险因素和合并症:对大型真实世界数据集的分析。
BMC Pregnancy Childbirth. 2021 Jan 22;21(1):76. doi: 10.1186/s12884-021-03558-2.